Broadwood Partners Reiterates Opposition to STAAR Surgical's Sale to Alcon Following Conclusion of Performative Go-Shop Process

Core Viewpoint - Broadwood Partners, L.P. and its affiliates, owning 30.2% of STAAR Surgical Company's outstanding common stock, oppose the proposed sale of the Company to Alcon Inc. on unchanged transaction terms following a flawed process [1] Group 1 - Broadwood Partners holds a significant stake of 30.2% in STAAR Surgical Company [1] - The proposed sale to Alcon Inc. is being contested by Broadwood due to concerns over the transaction terms [1] - The process leading to the proposed sale has been described as flawed by Broadwood [1]